Albert Cha

Managing Partnerat Frazier Life Sciences Management, LP· CA
Current roles
2
Investments attributed
7
Board seats
4
Form D directors and board-seat deals
More
Ask DFX about thisView relationshipsFind contactsInvestmentsBoard seats
As of · this person's identity; each section below carries its own date

2 additional roles and seats, 4 additional attributed investments

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. 2021
    since

    Managing Partner at Frazier Life Sciences Management, LP since 1 Nov 2021.

    Tenure says how settled this partner is at the firm.

    FactForm ADV Schedule A and the firm's team pageFor Founders, LPsRoles →
Drawing the relationship network…
Roles
1 current, 1 past
  • Frazier Life Sciences Management, LP Managing Partner
    Nov 1, 2021 to present · “Schedule A: CHA, ALBERT, (NMN), MANAGING PARTNER, since 11/2021, ownership NA, control person Y”
  • Vivo Capital, LLC Managing Partner
    Jun 1, 2005 to Sep 9, 2020 · “Listed on Schedule A of filing 2020-08-31 as MANAGING PARTNER, absent from filing 2020-09-09”
    Inference Form ADV
Investments attributed to this person
7
CompanyRoundInvestorAttributionDateSource
Aclaris Therapeutics, Inc.Form D equity offering · $10.6MVivo Capital, LLCstrongly supported · boardOct 8, 2014Inference sec.gov
Aclaris Therapeutics, Inc.Form D equity offering · $20.9MVivo Capital, LLCstrongly supported · boardSep 10, 2012Inference sec.gov
Yaupon Therapeutics IncForm D equity offering · $8.3MVivo Capital, LLCstrongly supported · boardMay 22, 2012Inference sec.gov
Board seats and vehicles
4 boards, 4 vehicles
Timeline
7 dated entries: events, attributed deals, board seats and role changes
  1. Nov 1, 2021
    Joined Frazier Life Sciences Management, LP as Managing Partner
    Role began Fact Frazier Life Sciences Management, LP Form ADV
  2. Sep 9, 2020
    Albert (nmn) Cha (Managing Partner) no longer on Schedule A of Vivo Capital, LLC
    Person left Inference Vivo Capital, LLC Form ADV
  3. Sep 9, 2020
    Left Vivo Capital, LLC as Managing Partner
    Role ended Inference Vivo Capital, LLC Form ADV
  4. Oct 8, 2014
    Form D equity offering in Aclaris Therapeutics, Inc. (Vivo Capital, LLC)
    Attributed investment Inference Aclaris Therapeutics, Inc. Form D
  5. Sep 10, 2012
    Form D equity offering in Aclaris Therapeutics, Inc. (Vivo Capital, LLC)
    Attributed investment Inference Aclaris Therapeutics, Inc. Form D
Full timeline · 7 entriesnewest first
  1. Nov 1, 2021
    Joined Frazier Life Sciences Management, LP as Managing Partner
    Role began Fact Frazier Life Sciences Management, LP Form ADV
  2. Sep 9, 2020
    Albert (nmn) Cha (Managing Partner) no longer on Schedule A of Vivo Capital, LLC
    Person left Inference Vivo Capital, LLC Form ADV
  3. Sep 9, 2020
    Left Vivo Capital, LLC as Managing Partner
    Role ended Inference Vivo Capital, LLC Form ADV
  4. Oct 8, 2014
    Form D equity offering in Aclaris Therapeutics, Inc. (Vivo Capital, LLC)
    Attributed investment Inference Aclaris Therapeutics, Inc. Form D
  5. Sep 10, 2012
    Form D equity offering in Aclaris Therapeutics, Inc. (Vivo Capital, LLC)
    Attributed investment Inference Aclaris Therapeutics, Inc. Form D
  6. May 22, 2012
    Form D equity offering in Yaupon Therapeutics Inc (Vivo Capital, LLC)
    Attributed investment Inference Yaupon Therapeutics Inc Form D
  7. Jun 1, 2005
    Joined Vivo Capital, LLC as Managing Partner
    Role began Inference Vivo Capital, LLC Form ADV

Relationships across DFX

on 1 other DFX graph
Across the graphs

Albert Cha is the same institution as 1 record in Private Equity.

Private Equity1

The joined record opens with the product, beside every other relationship on this page.

Checking your plan…

Record history

1 dated event on the change ledger, latest event first
  • Person left
    2020-09-09source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.